Hong Kong Financial Secretary Paul Chan Says City Ready to Be Biotech Bridge Connecting Global Capital with Chinese Innovation
Financial Secretary Paul Chan stated in an address to the Biotechnology Investment Forum of BIOHK2026 on Thursday that Hong Kong is poised to be the "partner of choice" for linking global capital with Chinese biotech innovation. Chan highlighted Hong Kong's position as the world's second-largest biotech fundraising platform, with nearly 300 healthcare companies listed on the Hong Kong Stock Exchange, boasting a combined market capitalization exceeding US$480 billion. He also noted that the Hong Kong Investment Corporation has allocated 22 percent of its funds to the biotech sector.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
stated at the 35th annual CASPA conference held in the US on October 23rd that AI infrastructure investment is facing multiple challenges
-
2
UAE's oil supply rebounded to a record high of 5.3 million barrels per day (bpd) in September
-
3
TREAT Token: An Analysis of the Core Token in the Shiba Inu Ecosystem
-
4
UN and human rights organizations condemn Israeli evictions in Hebron, while Israeli ministers express support.
-
5
Bulgarians are voting in a presidential election today
-
6
Mishaboar posted on X, proposing several measures for the growth of the Dogecoin ecosystem
-
7
X100 Exploit Proceeds Split Into Four 400-ETH Wallets
-
8
A Review of Major Global Digital Currency Trading Platforms and Selection Considerations
-
9
Sri Lanka's real estate market is experiencing a luxury property boom
-
10
Tokio Marine to offer insurance for AI-enabled robots from next month, with premiums 20% higher than regular industrial counterparts
Markets Today
Recommended Reading



